RSS   Newsletter   Contact   Advertise with us

HTG Molecular Diagnostics promotes John Lubniewski to COO

Staff Writer | Tucson, Az., USA | April 18, 2018
HTG Molecular DiagnosticsHTG Molecular Diagnostics, a provider of instruments and reagents for NGS-based molecular profiling applications, announced the promotion of John Lubniewski to president and chief operating officer.
Mr. Lubniewski has served as HTG’s chief business officer for the past seven years.

He joined HTG from Ventana, a medical diagnostics company and member of the Roche Group and global headquarters of Roche Tissue Diagnostics, or RTD.

During his time at Ventana, Mr. Lubniewski served in several senior leadership roles and was responsible for marketing and global accountability for all clinical assay products.

Prior to the acquisition by Roche, Mr. Lubniewski was responsible for a variety of assay and platform development and commercialization efforts across the company.

Prior to Ventana, he spent over a decade working at Corning, Inc., a manufacturing company, in a variety of roles including divisional, sector, and corporate sales, and marketing roles.

Mr. Lubniewski earned a B.S. in Chemical Engineering from Clarkson University.